|
Re: Resverlogix Closes Extension of Maturity Date of Loan and Announces Private Placement
|
4
|
Resverlogix Corp.
|
Sep 07, 2017 10:56AM
|
|
Re: Resverlogix Closes Extension of Maturity Date of Loan and Announces Private Placement
|
3
|
Resverlogix Corp.
|
Sep 07, 2017 01:35PM
|
|
Re: Resverlogix Closes Extension of Maturity Date of Loan and Announces Private Placement
|
3
|
Resverlogix Corp.
|
Sep 07, 2017 01:45PM
|
|
Re: Resverlogix Closes $10 Million of Equity Subscriptions
|
3
|
Resverlogix Corp.
|
Jun 20, 2017 11:34AM
|
|
Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication
|
4
|
Resverlogix Corp.
|
Mar 24, 2020 04:17PM
|
|
Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication
|
3
|
Resverlogix Corp.
|
Mar 26, 2020 05:55PM
|
|
Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication
|
3
|
Resverlogix Corp.
|
Mar 26, 2020 06:19PM
|
|
Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication
|
3
|
Resverlogix Corp.
|
Mar 27, 2020 01:11PM
|
|
Re: RESVERLOGIX ANNOUNCES. $15.1 MILLION OF PRIVATE PLACEMENTS
|
6
|
Resverlogix Corp.
|
Apr 01, 2019 04:43PM
|
|
Re: RESVERLOGIX ANNOUNCES WARRANT EXERCISE INCENTIVE PROGRAM
|
5
|
Resverlogix Corp.
|
Nov 25, 2019 07:55PM
|
|
Re: RESVERLOGIX ANNOUNCES WARRANT EXERCISE INCENTIVE PROGRAM
|
1
|
Resverlogix Corp.
|
Nov 25, 2019 08:05PM
|
|
Re: Resverlogix Announces US$30 Million Loan Commitment Letter .
|
5
|
Resverlogix Corp.
|
Apr 11, 2018 07:59AM
|
|
Re: Resverlogix Announces Publication on Apabetalone in Atherosclerosis Journal
|
3
|
Resverlogix Corp.
|
Nov 28, 2018 09:42AM
|
|
Re: RESVERLOGIX ANNOUNCES PUBLICATION OF KEY APABETALONE STUDY BETONMACE IN THE JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
|
3
|
Resverlogix Corp.
|
Apr 01, 2020 01:09PM
|
|
Re: RESVERLOGIX ANNOUNCES PUBLICATION OF KEY APABETALONE STUDY BETONMACE IN THE JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
|
2
|
Resverlogix Corp.
|
Apr 01, 2020 04:15PM
|
|
Re: RESVERLOGIX ANNOUNCES PUBLICATION OF KEY APABETALONE STUDY BETONMACE IN THE JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
|
3
|
Resverlogix Corp.
|
Mar 30, 2020 11:45PM
|
|
Re: RESVERLOGIX ANNOUNCES PUBLICATION OF KEY APABETALONE STUDY BETONMACE IN THE JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
|
5
|
Resverlogix Corp.
|
Mar 31, 2020 03:42PM
|
|
Re: RESVERLOGIX ANNOUNCES PUBLICATION OF KEY APABETALONE STUDY BETONMACE IN THE JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
|
4
|
Resverlogix Corp.
|
Mar 31, 2020 04:38PM
|
|
Re: RESVERLOGIX ANNOUNCES PUBLICATION OF KEY APABETALONE STUDY BETONMACE IN THE JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
|
2
|
Resverlogix Corp.
|
Mar 31, 2020 06:34PM
|
|
Re: RESVERLOGIX ANNOUNCES PUBLICATION OF KEY APABETALONE STUDY BETONMACE IN THE JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
|
2
|
Resverlogix Corp.
|
Mar 31, 2020 08:01PM
|
